Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
38 hedge funds and large institutions have $1.15M invested in Chembio diagnostics, Inc. in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 4 closing their positions.
660% more call options, than puts
Call options by funds: $38K | Put options by funds: $5K
0% more funds holding
Funds holding: 38 → 38 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
27% less capital invested
Capital invested by funds: $1.58M → $1.15M (-$422K)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$312K |
| 2 |
Millennium Management
New York
|
+$131K |
| 3 |
Renaissance Technologies
New York
|
+$61.5K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$53.2K |
| 5 |
S
SignatureFD
Atlanta,
Georgia
|
+$23.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$45K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$15.7K |
| 3 |
Jane Street
New York
|
-$15K |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$11K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$4.99K |
CEMI Hedge Fund Activity: Q3 2022 in Review
38 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q3 2022, worth a combined $1.15M — down 27% from $1.58M a quarter earlier.
Fund positioning in CEMI was balanced in Q3 2022: 4 funds opened new positions, 4 closed out, 6 added to existing stakes and 11 trimmed.
The largest buyer was Vanguard Group, adding an estimated $312K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $45K sold.
- 38 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $1.15M of Chembio diagnostics, Inc. stock for Q3 2022, down 27% quarter-over-quarter.
- 4 funds opened new Chembio diagnostics, Inc. positions in Q3 2022 and 4 closed out, a net change of 0 holders.
- The largest Chembio diagnostics, Inc. buyer in Q3 2022 was Vanguard Group, an estimated $312K added.
- The largest Chembio diagnostics, Inc. seller in Q3 2022 was Susquehanna International Group, an estimated $45K sold.
Based on aggregated 13F filings for Q3 2022.